oregon1974 Posted - 1 day ago

$CERS Will cover short after earnings report which should send this to a buck.

2019Bull2025 Posted - 5 days ago

$CERS feels like it’s time to fly

BioGem Posted - 1 week ago

$CERS Went long, many positives: -Strong moat, minimal competition, regulatory protection, and monopoly in many countries. -Baker brothers own >10% + added in 2023. -In late 2023, directors bought stock + high CEO ownership. -Compensation tied to performance in operations and financials. -BARDA supports R&D = a ton of free value for shareholders. -The inventory buildup and shelf-life issues from 2023 have now resolved and inventories are drawn = expect YOY growth in 2024. -Cut back on operating expenses in 23 = expanding margins in 2024. Q4 financial statement was the best in its recent history. -Achieved breakeven on adj EBIDTA in Q4 and to be sustained through 24 = closer to cash breakeven. Catalysts: Q4 2024: EU RBC approval and launch. $XBI $IBB

Aigner_Andreas Posted - 1 week ago

TD BUY $CERS at 1.68, Supp 1.64 Resis 1.90 R16 HiLo 24% T1Y 9 strong_buy 1.4 DIV N/A #Cerus Corp #stocks #trading #finance #market

2019Bull2025 Posted - 1 week ago

$CERS K11648979 G8144166

Stock_Titan Posted - 1 week ago

$CERS Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024 https://www.stocktitan.net/news/CERS/cerus-corporation-to-release-first-quarter-2024-financial-results-on-tn00ov0970q9.html

oregon1974 Posted - 1 week ago

$CERS Will cover at a buck. Trash stock with no volume.

BeefStewart Posted - 1 week ago

$CERS

2019Bull2025 Posted - 2 weeks ago

$CERS they might it’s always a possibility take this thing lower before taking it higher. I’m glad one analyst at least came out and spit the truth

DonCorleone77 Posted - 2 weeks ago

$CERS Craig-Hallum starts Cerus at Buy, sees shares more than doubling Craig-Hallum initiated coverage of Cerus with a Buy rating and $5 price target. The analyst says Cerus plays a critical role in the U.S. and global blood supply system. The firm estimates 80% to 85% of all blood centers in the U.S. use the company's Intercept Blood System, and that 60% to 65% of all U.S. transfused platelets are treated with this technology. The firm sees Cerus returning to growth in 2024 and finds the stock's risk/reward compelling at current share levels. Hallum believes the stock should more than double over the next 12 months.

HorizonBull Posted - 2 weeks ago

$CERS opportunity to add cheap toda

oregon1974 Posted - 2 weeks ago

$CERS POS stock and still short. Will cover at a buck.

2019Bull2025 Posted - 2 weeks ago

$CERS somebody stated that insiders are buying on this platform, I got zero proof and I’ve looked that insiders are buying. Can’t say the same thing about Pacificbio sciences, insiders are buying

TickerDD_com Posted - 2 weeks ago

From 4/3/2024, looking back across 22 Month-Ends for CERS, Percentage Change of Average Monthly Price had More Negatives (59%) while Percentage Change of Average Monthly Volume had More Positives (95%) $CERS #CERS #CERSStock #TickerDD https://www.youtube.com/watch?v=2oCtkmTGrgU

2019Bull2025 Posted - 2 weeks ago

$CERS K 11827503 G 8034887

BeefStewart Posted - 3 weeks ago

$CERS Looks like it might close green today. Congratulations to anyone who successfully traded this one. I would sincerely appreciate it if anyone could offer insight into the bull thesis here. Cathie Wood looks to be accumulating, but that does not guarantee anything. How does the technology compete with existing products? Do the long-term prospects seem promising? I have only received messages about the usual bull vs. bear hate-rhetoric. It would be so nice to hear someone articulate why they are bullish here. Thanks in advance.

2019Bull2025 Posted - 3 weeks ago

$CERS 11916744 k 8136880 g

oregon1974 Posted - 3 weeks ago

$CERS Down again as usual. Been a great short. Going lower.

DailyStocksPicks Posted - 03/30/24

Today's Pick #3: Despite a drop in stock price and a sell rating from Argus Research, $OSUR outperformed earnings expectations and demonstrated revenue growth, leading to debate about the stock being oversold. Wall Street maintains a moderate buy consensus, seeing potential in the company despite the bearish trend. $ANIK, $CERS, $UTMD, $ATRI For More Details: https://youtu.be/jctblbaaOaI

Turkeycock Posted - 4 weeks ago

$CERS

Stockbricks Posted - 4 weeks ago

$CERS Cathy playing wicked imo

Stockbricks Posted - 1 month ago

$CERS this is one F**ed up stock playing like a ball with the hedges.

tjfarnham Posted - 1 month ago

$CERS I’m doubling down before the rise.

Stockbricks Posted - 1 month ago

$CERS they shorted it even with FDA approvals and good news. Markets are very strange and illogical $SPY $SOUN $PAYS $MESO

HorizonBull Posted - 1 month ago

$CERS

BeefStewart Posted - 1 month ago

$CERS @Rezkin Good morning Ray, I'd greatly appreciate it if you could share some of your reasons for being bullish here. Thank you in advance.

2019Bull2025 Posted - 1 month ago

$CERS K 12114 plus G 8166 plus

ujinworld Posted - 1 month ago

$CERS $20🧨

Stock_Titan Posted - 1 month ago

$CERS Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life https://www.stocktitan.net/news/CERS/cerus-corporation-announces-fda-approval-of-extended-shelf-life-for-okanflexi0g4.html

Stockbricks Posted - 1 month ago

$CERS seriously whats going on here $SGMT $BBAi $CLSK $SOUN